Gradient

Collectively, the NeurAegis Leadership Team has...

Leadership.png

Leadership Team

Michael_Baundry.png
Michel Baudry, Ph.D.
Founder & Chief Scientific Advisor

World-renowned neuroscientist, life science entrepreneur and professor. Co-Founder of 5 biotechnology companies across two countries. Identified calpain-2’s role in neurodegeneration and discovered novel calpain-2 protease inhibitors. Earned his Ph.D. (Biochemistry) from University Paris VII (Paris, France)

Stella.png
Stella M. Sung, Ph.D.
President & CEO

C-level (CEO/CBO) life Science/biotech executive with 25 years of experience in both operating and venture capital roles. Successful track record in negotiating, establishing, and executing transactions, agreements, and partnerships. Extensive experience in raising capital, building companies; served on or chaired Boards of >10 life science companies. Earned her Ph.D. (Chemistry) from Harvard University (National Science Foundation Pre-Doctoral Fellow).

Michael_Palfreyman.png
Michael Palfreyman, Ph.D., D.Sc. Drug Development Advisor

Scientific leader in pharmaceutical industry for over 40 years. Internationally recognized leader in neuropharmacology and drug development and clinical Proof of Concept. Successfully led multiple IND filings and clinical programs. Holds a D.Sc. and a Ph.D. degree in Pharmacology, both from the University of Nottingham, UK.

Key Managers

Shujaath.png
Shujaath Mehdi, Ph.D.
Biochemical Pharmacology
  • Sanofi, Merrell Dow

  • Ph.D. from Yale University (biochemistry)

Phillip.png
Philippe Bey, Ph.D.
Chemistry
  • ArQule, Sanofi Aventis, Hoechst Marion Roussel

  • Ph.D. from University Louis Pasteur (chemistry)

KathyF.png
Kathy Fosnaugh, Ph.D.
Program Management
  • Aminex Therapeutics, Sirna Therapeutics, Ligand Pharmaceuticals

  • Ph.D. from Cornell University (microbiology)

Scientific & Clinical Advisors

Diaz.png

 Ramon Diaz-Arrastia, M.D., Ph.D.

Presidential Professor of Neurology;

 Director of Clinical Traumatic Brain Injury (TBI) Research
University of Pennsylvania,

Perelman School of Medicine

Greg.png

 Greg Coulter, Ph.D.

Biological Chemistry,

University of Guelph, Canada

President, CTM Solutions, LLC

Pharmaceutical Development Specialist

Imad.png

 Imad Najm, M.D.

Director, Epilepsy Center

 Cleveland Clinic

Barry.png

 Barry Jordan, M.D., M.P.H.

Chief Medical Officer

 Rancho Los Amigos

National Rehabilitation Center

Independent Board Directors & Advisors

Malfroy.png

 Bernard Malfroy, Ph,D,

  • >40 Years in Drug Discovery & Development, 

  • Directly Responsible for Designing Several Biopharmaceutical Products

  • Currently CEO, ViThera Pharmaceuticals and Board member of Eyegate Pharma and NeurAegis, Inc.

Joe_Blanchard.png

Joe Blanchard, M.B.A.

  • Co-Founder, President & CEO, Amorsa Therapeutics

  • Co-Founder, COO, CBO, Aushon Biosystems (acquired by Quanterix in 2018)

  • Other previous positions at Altus Pharmaceuticals, Genencor International, and Akzo Nobel